Peter H. O'Donnell to Sleep Initiation and Maintenance Disorders
This is a "connection" page, showing publications Peter H. O'Donnell has written about Sleep Initiation and Maintenance Disorders.
Connection Strength
0.221
-
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. J Clin Oncol. 2024 Apr 20; 42(12):1403-1414.
Score: 0.221